Table 1 Characteristics of the participants of physical examinations by fasting plasma triglyceride categories (mmol/L) in men and women
Men, fasting plasma triglyceride (mmol/L) | Women, fasting plasma triglyceride (mmol/L) | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
No. of participants | < 1.21 | 1.21 ~ | 1.7 ~ | 2.83 ~ | > 5.6 | P-value | No. of participants | < 1.21 | 1.21 ~ | 1.7 ~ | 2.83 ~ | > 5.6 | P-value | |
No. of participants | 12,557 | 4293 (34.2) | 3040 (24.2) | 3335 (26.6) | 1546 (12.3) | 343 (2.7) | 11,881 | 6023 (50.7) | 2661 (22.4) | 2353 (19.8) | 747 (6.3) | 97 (0.8) | ||
Age (years), n (%) | ||||||||||||||
< 20 | 43 | 33 (76.7) | 4 (9.3) | 5 (11.6) | 0 (0.0) | 1 (2.3) | < 0.001 | 22 | 17 (77.3) | 3 (13.6) | 2 (9.1) | 0 (0.0) | 0 (0.0) | < 0.001 |
20 ~ | 1325 | 609 (46.0) | 324 (24.5) | 244 (18.4) | 125 (9.4) | 23 (1.7) | 1880 | 1335 (71.0) | 264 (14.0) | 190 (10.1) | 81 (4.3) | 10 (0.5) | ||
30 ~ | 2348 | 702 (29.9) | 540 (23.0) | 669 (28.5) | 342 (14.6) | 95 (4.1) | 2485 | 1582 (63.7) | 473 (19.0) | 324 (13.0) | 89 (3.6) | 17 (0.7) | ||
40 ~ | 3133 | 858 (27.4) | 704 (22.5) | 938 (29.9) | 505 (16.1) | 128 (4.1) | 2652 | 1496 (56.4) | 578 (21.8) | 436 (16.4) | 128 (4.8) | 14 (0.5) | ||
50 ~ | 2735 | 879 (32.1) | 680 (24.9) | 764 (27.9) | 349 (12.8) | 63 (2.3) | 2492 | 904 (36.3) | 679 (27.3) | 654 (26.2) | 224 (9.0) | 31 (1.2) | ||
60 ~ | 1848 | 684 (37.0) | 474 (25.7) | 510 (27.6) | 157 (8.5) | 23 (1.2) | 1509 | 424 (28.1) | 441 (29.2) | 480 (31.8) | 146 (9.7) | 18 (1.2) | ||
70 ~ | 848 | 386 (45.5) | 233 (27.5) | 166 (19.6) | 56 (6.6) | 7 (0.8) | 679 | 214 (31.5) | 172 (25.3) | 222 (32.7) | 64 (9.4) | 7 (1.0) | ||
80 ~ | 277 | 142 (51.3) | 81 (29.2) | 39 (14.1) | 12 (4.3) | 3 (1.1) | 162 | 51 (31.5) | 51 (31.5) | 45 (27.8) | 15 (9.3) | 0 (0.0) | ||
Alanine Aminotransferase (U/L), n (%) | ||||||||||||||
<= 40 | 10,864 | 3974 (36.6) | 2694 (24.8) | 2812 (25.9) | 1165 (10.7) | 219 (2.0) | < 0.001 | 11,289 | 5856 (51.9) | 2514 (22.3) | 2172 (19.2) | 661 (5.9) | 86 (0.8) | < 0.001 |
> 40 | 1693 | 319 (18.8) | 346 (20.4) | 523 (30.9) | 381 (22.5) | 124 (7.3) | 592 | 167 (28.2) | 147 (24.8) | 181 (30.6) | 86 (14.5) | 11 (1.9) | ||
γ-Glutamyl Transpeptidase (U/L), n (%) | ||||||||||||||
< 16 | 1722 | 1102 (64.0) | 375 (21.8) | 200 (11.6) | 39 (2.3) | 6 (0.4) | < 0.001 | 6207 | 4088 (65.9) | 1253 (20.2) | 716 (11.5) | 138 (2.2) | 12 (0.2) | < 0.001 |
16 ~ 73 | 9724 | 3077 (31.6) | 2509 (25.8) | 2766 (28.5) | 1168 (12.0) | 204 (2.1) | 5488 | 1892 (34.5) | 1364 (24.9) | 1578 (28.8) | 575 (10.5) | 79 (1.4) | ||
> 73 | 1111 | 114 (10.3) | 156 (14.0) | 369 (33.2) | 339 (30.5) | 133 (12.0) | 186 | 43 (23.1) | 44 (23.7) | 59 (31.7) | 34 (18.3) | 6 (3.2) | ||
Serum Creatinine (mmol/L), n (%) | ||||||||||||||
Men < 54 or Women < 44 | 719 | 281 (39.1) | 143 (19.9) | 168 (23.4) | 89 (12.4) | 38 (5.3) | < 0.001 | 1383 | 688 (49.8) | 311 (22.5) | 261 (18.9) | 107 (7.7) | 16 (1.2) | < 0.001 |
Men: 54~106 or Women: 44~97 | 11,715 | 3978 (34.0) | 2862 (24.4) | 3143 (26.8) | 1431 (12.2) | 301 (2.6) | 10,461 | 5325 (50.9) | 2339 (22.4) | 2085 (19.9) | 632 (6.0) | 80 (0.8) | ||
Men > 106 or Women > 97 | 123 | 34 (27.6) | 35 (28.5) | 24 (19.5) | 26 (21.1) | 4 (3.3) | 37 | 10 (27.0) | 11 (29.7) | 7 (18.9) | 8 (21.6) | 1 (2.7) | ||
Blood Urea Nitrogen (μmol/L), n (%) | ||||||||||||||
< 2.86 | 101 | 36 (35.6) | 23 (22.8) | 26 (25.7) | 12 (11.9) | 4 (4.0) | < 0.001 | 523 | 300 (57.4) | 110 (21.0) | 81 (15.5) | 30 (5.7) | 2 (0.4) | 0.027 |
2.86 ~ 7.14 | 11,465 | 3853 (33.6) | 2779 (24.2) | 3103 (27.1) | 1420 (12.4) | 310 (2.7) | 11,016 | 5570 (50.6) | 2469 (22.4) | 2196 (19.9) | 690 (6.3) | 91 (0.8) | ||
> 7.14 | 991 | 404 (40.8) | 238 (24.0) | 206 (20.8) | 114 (11.5) | 29 (2.9) | 342 | 153 (44.7) | 82 (24.0) | 76 (22.2) | 27 (7.9) | 4 (1.2) | ||
Total Cholesterol (mmol/L), n (%) | ||||||||||||||
< 2.8 | 82 | 66 (80.5) | 12 (14.6) | 3 (3.7) | 1 (1.2) | 0 (0.0) | < 0.001 | 44 | 34 (77.3) | 6 (13.6) | 4 (9.1) | 0 (0.0) | 0 (0.0) | < 0.001 |
2.8 ~ 5.17 | 7665 | 3252 (42.4) | 1878 (24.5) | 1777 (23.2) | 671 (8.8) | 87 (1.1) | 7273 | 4561 (62.7) | 1425 (19.6) | 970 (13.3) | 287 (4.0) | 30 (0.4) | ||
> 5.17 | 4810 | 975 (20.3) | 1150 (23.9) | 1555 (32.3) | 874 (18.2) | 256 (5.3) | 4564 | 1428 (31.3) | 1230 (27.0) | 1379 (30.2) | 460 (10.1) | 67 (1.5) | ||
Fasting plasma glucose (mmol/L), n (%) | ||||||||||||||
< 3.9 | 20 | 9 (45.0) | 6 (30.0) | 2 (10.0) | 3 (15.0) | 0 (0.0) | 20 | 9 (45.0) | 5 (25.0) | 3 (15.0) | 2 (10.0) | 1 (5.0) | < 0.001 | |
3.9 ~ | 9833 | 3591 (36.5) | 2447 (24.9) | 2521 (25.6) | 1062 (10.8) | 212 (2.2) | < 0.001 | 10,194 | 5607 (55.0) | 2217 (21.8) | 1814 (17.8) | 497 (4.9) | 59 (0.6) | |
6.1 ~ | 1370 | 368 (26.9) | 309 (22.6) | 416 (30.4) | 218 (15.9) | 59 (4.3) | 933 | 245 (26.3) | 263 (28.2) | 290 (31.1) | 119 (12.8) | 16 (1.7) | ||
> 7.0 | 1334 | 325 (24.4) | 278 (20.8) | 396 (29.7) | 263 (19.7) | 72 (5.4) | 734 | 162 (22.1) | 176 (24.0) | 246 (33.5) | 129 (17.6) | 21 (2.9) | ||
High Density Lipoprotein Cholesterol (mmol/L), n (%) | ||||||||||||||
< 0.9 | 2274 | 371 (16.3) | 465 (20.5) | 775 (34.1) | 502 (22.1) | 161 (7.1) | < 0.001 | 709 | 98 (13.8) | 134 (18.9) | 234 (33.0) | 197 (27.8) | 46 (6.5) | < 0.001 |
0.9 ~ 2.19 | 10,262 | 3904 (38.0) | 2573 (25.1) | 2559 (24.9) | 1044 (10.2) | 182 (1.8) | 11,093 | 5865 (52.9) | 2514 (22.7) | 2115 (19.1) | 548 (4.9) | 51 (0.5) | ||
> 2.19 | 21 | 18 (85.7) | 2 (9.5) | 1 (4.8) | 0 (0.0) | 0 (0.0) | 79 | 60 (76.0) | 13 (16.5) | 4 (5.1) | 2 (2.5) | 0 (0.0) | ||
Hyperuricemia (men > 440 μmol/L or women > 360 μmol/L) | ||||||||||||||
No | 11,305 | 4068 (36.0) | 2791 (24.7) | 2948 (26.1) | 1246 (11.0) | 252 (2.2) | < 0.001 | 11,193 | 5877 (52.5) | 2507 (22.4) | 2112 (18.9) | 614 (5.5) | 83 (0.7) | < 0.001 |
Yes | 1252 | 225 (18.0) | 249 (19.9) | 387 (30.9) | 300 (24.0) | 91 (7.3) | 688 | 146 (21.2) | 154 (22.4) | 241 (35.0) | 133 (19.3) | 14 (2.0) | ||